Oncology & Cancer

Cell-cycle progression panel identifies prostate cancer risk

(HealthDay)—The cell-cycle progression (CCP) gene panel is useful to improve the risk stratification for men with even low-risk, clinically localized prostate cancer, according to research published online March 4 in the ...

Oncology & Cancer

New guidelines issued for pediatric fever and neutropenia

(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; the guidelines ...

Cardiology

New model better predicts risk of post-PCI bleeding

(HealthDay)—A new definition of post-percutaneous coronary intervention (PCI) bleeding and a new predictive risk model can better identify patients at risk for bleeding complications, according to a study published in the ...

Cardiology

Coronary artery calcium score improves CHD risk prediction

(HealthDay)—Inclusion of the coronary artery calcium (CAC) score improves coronary heart disease (CHD) risk prediction, while the absence of CAC reclassifies many patients as not eligible for statins, according to two studies ...

Oncology & Cancer

Financial hardship common among colon cancer patients

(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March ...

Ophthalmology

Improved vision from cataract surgery appears to aid survival

(HealthDay)—Surgical correction of visual impairment (VI) due to cataract is associated with significantly better long-term survival in older persons after adjusting for known cataract and mortality risk factors and indicators ...

Oncology & Cancer

Q&A: What your home region reveals about your cancer risk

For many types of cancer, the incidence rate is decreasing—but according to a new study some regions are benefiting considerably more from this trend than others. Health economist Lars Schwettmann explains the connections.

page 4 from 9